Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.
D K Henderson, … , J E Bennett, M A Huber
D K Henderson, … , J E Bennett, M A Huber
Published May 1, 1982
Citation Information: J Clin Invest. 1982;69(5):1185-1190. https://doi.org/10.1172/JCI110555.
View: Text | PDF
Research Article

Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis.

  • Text
  • PDF
Abstract

A sensitive radioimmunoassay and an antibody class-specific enzyme-linked immunosorbent assay were used to determine whether patients cured of cryptococcosis responded normally to immunization with cryptococcal capsular polysaccharide (CPS) and type III pneumococcal polysaccharide. 10 normal volunteers and 8 patients who had been cured of cryptococcal meningitis and who had been cured of cryptococcal meningitis and who had no serious underlying diseases were immunized with both antigens. Geometric mean titers to CPS measured by radioimmunoassay were 1:1 in both groups before vaccination, but were 1:3 in patients and 1:119 in controls following immunization (P less than 0.01, Student's t test). Analysis of the class-specific response to immunization with CPS found little anti-CPS IgG or IgA. Geometric mean postvaccination IgM titers were 1:31 in patients and 1:238 in controls (P less than 0.01). Responses to immunization with type III pneumococcal polysaccharide were similar in patients and controls, with IgA, IgM, and IgG mean titers of 1:1129, 1:369, and 1:158 in patients and 1:1504, 1:1039, and 1:163 in controls (P greater than 0.2 for each antibody class). Cured cryptococcal meningitis is often associated with prolonged specific immunologic unresponsiveness.

Authors

D K Henderson, J E Bennett, M A Huber

×

Total citations by year

Year: 2011 2010 2008 2007 2006 2005 2004 2003 2001 1999 1998 1997 1996 1995 1994 1993 1991 1990 1989 1988 1987 1986 1985 Total
Citations: 1 3 1 1 1 1 1 1 1 4 3 2 4 7 1 1 3 1 3 2 2 1 2 47
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (47)

Title and authors Publication Year
The Cu regulon of the human fungal pathogen Cryptococcus neoformans H99: Cuf1 activates distinct genes in response to both Cu excess and deficiency
C Ding, J Yin, EM Tovar, DA Fitzpatrick, DG Higgins, DJ Thiele
Molecular Microbiology 2011
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010
National Institute of Allergy and Infectious Diseases, NIH
VS Georgiev
2010
Cryptococcus: From Human Pathogen to Model Yeast
J Heitman, TR Kozel, KJ Kwon-Chung, JR Perfect, A Casadevall
2010
Fungal Infections
Chimelli L, Mahler\u2010Araújo MB
Brain Pathology 2008
Immunology of Fungal Infections
GD Brown, MG Netea
2007
Molecular Principles of Fungal Pathogenesis
J Heitman, SG Filler, JE Edwards, AP Mitchell
2006
Effect of Amphotericin B on Capsule and Cell Size in Cryptococcus neoformans during Murine Infection
O Zaragoza, C Mihu, A Casadevall, JD Nosanchuk
Antimicrobial agents and chemotherapy 2005
Cryptococcose
F Dromer, O Lortholary
EMC - Maladies Infectieuses 2004
Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis
W He, A Casadevall, SC Lee, DL Goldman
Infection and immunity 2003
Cyclic AMP-Dependent Protein Kinase Controls Virulence of the Fungal Pathogen Cryptococcus neoformans
CA D'Souza, JA Alspaugh, C Yue, T Harashima, GM Cox, JR Perfect, J Heitman
Molecular and cellular biology 2001
Serum antibody response to Cryptococcus neoformans in cats, dogs and koalas with and without active infection
R Malik, BR Speed, J Kaldor, B Cairns, M Pegorer, DI Wigney, DN Love
Medical Mycology 1999
Serum antibody response toCryptococcus neoformansin cats, dogs and koalas with and without active infection
R Malik, BR Speed, J Kaldor, B Cairns, M Pegorer, DI Wigney, DN Love
Medical Mycology 1999
Epidemiological evidence for dormant Cryptococcus neoformans infection
D Garcia-Hermoso, G Janbon, F Dromer
Journal of clinical microbiology 1999
Epidemiological Evidence for Dormant Cryptococcus neoformans Infection
D Garcia-Hermoso, G Janbon, F Dromer
Journal of clinical microbiology 1999
What makes Cryptococcus neoformans a pathogen?
KL Buchanan, JW Murphy
Emerging infectious diseases 1998
Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity
A Vecchiarelli, A Casadevall
Research in Immunology 1998
Cryptococcus neoformans
A Casadevall, JR Perfect
1998
Fungal Infections
L Chimelli, MB Mahler-Araújo
Brain Pathology 1997
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis
AC Savoy, DM Lupan, PB Manalo, JS Roberts, AM Schlageter, LC Weinhold, TR Kozel
Infection and immunity 1997
Serum antibody response to active infection withCryptococcus neoformansand its varieties in immunocompetent subjects
BR Speed, J Kaldor, B Cairns, M Pegorer
Medical Mycology 1996
Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis
SC Lee, A Casadevall, DW Dickson
The American Journal of Pathology 1996
Cryptococcus neoformans: Paradigm for the Role of Antibody Immunity Against Fungi?
LA Pirofski, A Casadevall
Zentralblatt für Bakteriologie 1996
Exposure to Cryptococcus neoformans var. gattii — a seroepidemiological study
RA Seaton, AJ Hamilton, RJ Hay, DA Warrell
Transactions of the Royal Society of Tropical Medicine and Hygiene 1996
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV− individuals
M Deshaw, LA Pirofski
Clinical & Experimental Immunology 1995
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
TG Mitchell, JR Perfect
Clinical microbiology reviews 1995
Antibody immunity and invasive fungal infections
A Casadevall
Infection and immunity 1995
Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals
M Deshaw, LA Pirofski
Clinical & Experimental Immunology 1995
Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody
DL Goldman, SC Lee, A Casadevall
Infection and immunity 1995
Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine
L Pirofski, R Lui, M DeShaw, AB Kressel, Z Zhong
Infection and immunity 1995
Anti-Cryptococcus neoformans antibodies during cryptococcosis in patients with the acquired immunodeficiency syndrome
F Dromer, DW Denning, DA StevenS, A Noble, JR Hamilton
Serodiagnosis and Immunotherapy in Infectious Disease 1995
Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan
DC Houpt, GS Pfrommer, BJ Young, TA Larson, TR Kozel
Infection and immunity 1994
Fungal Infections and Immune Responses
JW Murphy, H Friedman, M Bendinelli
1993
Killing of Cryptococcus neoformans strains by human neutrophils and monocytes
MF Miller, TG Mitchell
Infection and immunity 1991
Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity
SJ Devi, R Schneerson, W Egan, TJ Ulrich, D Bryla, JB Robbins, JE Bennett
Infection and immunity 1991
Fungal Cell Wall and Immune Response
JP Latgé, D Boucias
1991
Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody
MF Miller, TG Mitchell, WJ Storkus, JR Dawson
Infection and immunity 1990
Current concepts in Cryptococcosis
TF Patterson, VT Andriole
European Journal of Clinical Microbiology & Infectious Diseases 1989
Candida Cell Wall Mannan: A Polysaccharide with Diverse Immunologic Properties
JE Domer
Critical Reviews in Microbiology 1989
Cryptococcosis
JR Perfect
Infectious Disease Clinics of North America 1989
Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice
F Dromer, P Yeni, J Charreire
Immunogenetics 1988
Cryptococcal meningitis presenting as uveitis
SP Stone, J Bendig, J Hakim, PE Kinnear, BS Azadian, F Clifford-Rose
The British journal of ophthalmology 1988
Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
F Dromer, J Charreire, A Contrepois, C Carbon, P Yeni
Infection and immunity 1987
Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide
F Dromer, J Salamero, A Contrepois, C Carbon, P Yeni
Infection and immunity 1987
Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro
DK Henderson, VL Kan, JE Bennett
Clinical & Experimental Immunology 1986
Immunology of fungal infections in animals
PF Lehmann
Veterinary Immunology and Immunopathology 1985
Selective Antibody Deficiency and Recurrent Pneumococcal Bacteremia in a Patient with Sjögren's Syndrome, Hyperimmunoglobulinemia G, and Deficiencies of IgG2 and IgG4
L Matter, JA Wilhelm, W Angehrn, F Skvaril, K Schopfer
New England Journal of Medicine 1985

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts